PENNY DUNNING- NEWELL: Open Payments
NPI 1194758987 · GRAVOIS MILLS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 16 payments from 7 companies in 2025. Trend: 2023 $325 · 2024 $342 · 2025 $323
Food & beverage: $323
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $117 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $53 |
| Dexcom, Inc. | 2 | $51 |
| Alkermes, Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
Products named: CAPLYTA, JOURNAVX, Dexcom G6 Transmitter, REXULTI, ARISTADA, VIVITROL, FANAPT, VRAYLAR.
Industry payments across MO — which companies pay providers there.
